Skip to content

HONEYPATCH

Active
Private limited companyfounded 2013active for 13 yearsQuai Banning 6, 4000 Liège, Belgium54 active companies are registered at this addressKBO/BCE: BE 0524.896.791
Summary

The computed 12-month bankruptcy probability of HONEYPATCH is 3.8% (moderate). The 2024 annual accounts show negative equity (-€388,117) and a net result of -€144,190. Equity is shrinking by about 14% per year across the filed financial years. Its solvency ranks better than 14% of 86 sector peers (NACE 21, financial year 2024). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.

Financials · financial year 2024, micro format

2025 annual accounts not yet filed, deadline passed on 31 July 2026 Financial year closed on 31 December 2025; filing due at the latest 7 months after the close (Companies Code art. 3:10). Source: NBB filings, as of 17 October 2026.

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€144,190▼ 278%
2023 · -€38,177
Working capital
-€25,452
2023 · €100,958
Trend over the years

2020 to 2024, 5 financial years 2018 to 2024, 7 financial years

The operating result stays negative: a loss of €123,418 in 2024 against €23,227 in 2023; the loss grows and 2024 has the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€123,418 2024 Net result-€144,190 2024

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line2018201920202021202220232024
Operating result-€110,989--€46,893▲ 57.7%-€61,951▼ 32.1%-€8,989▲ 85.5%-€4,406▲ 51.0%-€23,227▼ 427%-€123,418▼ 431%
Net result-€113,808--€55,002▲ 51.7%-€71,741below the sector's middle half▼ 30.4%-€15,722within the sector's middle half▲ 78.1%-€10,976within the sector's middle half▲ 30.2%-€38,177below the sector's middle half▼ 248%-€144,190below the sector's middle half▼ 278%
Equity-€103,751--€158,753▼ 53.0%-€180,094below the sector's middle half▼ 13.4%-€195,816below the sector's middle half▼ 8.7%-€206,792below the sector's middle half▼ 5.6%-€243,926below the sector's middle half▼ 18.0%-€388,117below the sector's middle half▼ 59.1%
Total assets€358,477-€359,889▲ 0.4%€356,905below the sector's middle half▼ 0.8%€371,156within the sector's middle half▲ 4.0%€392,197within the sector's middle half▲ 5.7%€430,128within the sector's middle half▲ 9.7%€330,409within the sector's middle half▼ 23.2%
Debt€462,228-€518,642▲ 12.2%€536,998▲ 3.5%€566,972▲ 5.6%€598,989▲ 5.6%€674,054▲ 12.5%€718,526▲ 6.6%
Working capital€52,875-€35,900▼ 32.1%€49,139within the sector's middle half▲ 36.9%€11,588within the sector's middle half▼ 76.4%-€6,787within the sector's middle half€100,958within the sector's middle half-€25,452below the sector's middle half
Solvency-28.9%--44.1%▼ 15.2pp-50.5%below the sector's middle half▼ 6.3pp-52.8%below the sector's middle half▼ 2.3pp-52.7%below the sector's middle half=-56.7%below the sector's middle half▼ 4.0pp-117.5%below the sector's middle half▼ 60.8pp
Current ratio1.44-1.40▼ 0.041.80within the sector's middle half▲ 0.401.13within the sector's middle half▼ 0.680.95within the sector's middle half▼ 0.182.02within the sector's middle half▲ 1.070.85within the sector's middle half▼ 1.17
Return on assets (ROA)-31.7%--15.3%▲ 16.5pp-20.1%below the sector's middle half▼ 4.8pp-4.2%within the sector's middle half▲ 15.9pp-2.8%within the sector's middle half▲ 1.4pp-8.9%below the sector's middle half▼ 6.1pp-43.6%below the sector's middle half▼ 34.8pp
Staff (FTE)2-1.8▼ 10.0%1.62▲ 25.0%2.4▲ 20.0%3.5▲ 45.8%
above within below the middle half of NACE 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €330,409
Fixed assets €183,151 ▼ 20.4%
Current assets €147,258 ▼ 26.4%
Equity and liabilities
Equity-€388,117
Debt€718,526
Equity is negative: debt (€718,526) exceeds the balance-sheet total (€330,409).
Key figures and ratios
2024 value · change against 2023
EBITDA
-€72,781▼
2023 · €27,278
Cash flow
-€93,554▼
2023 · €12,328
Quick ratio
0.24▼
2023 · 0.82
Interest coverage
-3.50▼
2023 · 1.74
Debt ≤ 1 year
€172,710▲
2023 · €99,054
Debt > 1 year
€545,815▼
2023 · €575,000
Staff costs
€60,859▼
2023 · €79,067
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,906 companies that looked in July 2024 the way this one looks now, 5.8% went bankrupt within 24 months and 85.5% are still going.

  • Micro
  • 10 to 20 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
5.8% went bankrupt
8.1% stopped otherwise
85.5% still going

A further 0.6% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 3.8% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,906 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 46 lines
Balance sheet Code20232024
Assets
Total assets20/58€430,128€330,409▼
Fixed assets21/28€230,116€183,151▼
Intangible fixed assets21€212,195€170,747▼
Tangible fixed assets22/27€15,310€9,793▼
Plant, machinery and equipment23€137-
Furniture and vehicles24€15,173€9,793▼
Financial fixed assets28€2,611€2,611=
Current assets29/58€200,011€147,258▼
Stocks and contracts in progress3€118,791€105,675▼
Stocks30/36€118,791€105,675▼
Amounts receivable within one year40/41€51,611€14,995▼
Trade receivables40€45,360€14,995▼
Other amounts receivable41€6,252-
Cash at bank and in hand54/58€16,330€13,309▼
Deferred charges and accrued income490/1€13,279€13,279=
Equity and liabilities
Total equity and liabilities10/49€430,128€330,409▼
Equity10/15-€243,926-€388,117▼
Contributions10/11€200,400€200,400=
Profit (loss) carried forward14-€444,326-€588,517▼
Amounts payable17/49€674,054€718,526▲
Amounts payable after more than one year17€575,000€545,815▼
Financial debts170/4€575,000€545,815▼
Amounts payable within one year42/48€99,054€172,710▲
Financial debts43€2,339€9,304▲
Credit institutions430/8€2,339€9,304▲
Trade debts44€4,927€3,667▼
Suppliers440/4€4,927€3,667▼
Taxes, remuneration and social security45€10,734€8,067▼
Taxes450/3€4,578€1,718▼
Remuneration and social security454/9€6,156€6,349▲
Other amounts payable47/48€81,054€151,672▲
Income statement Code20232024
Non-recurring operating income76A-€461
Remuneration, social security and pensions62€79,067€60,859▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€50,505€50,636▲
Other operating charges640/8-€1,248
Non-recurring operating charges66A€7,002€5,558▼
Gross operating margin9900€113,346-€5,116▼
Operating profit (loss)9901-€23,227-€123,418▼
Financial charges65/66B€15,701€20,773▲
Recurring financial charges65€15,701€20,773▲
Profit (loss) for the period before taxes9903-€38,928-€144,190▼
Income taxes67/77-€751-
Profit (loss) for the period9904-€38,177-€144,190▼
Profit (loss) for the period to be appropriated9905-€38,177-€144,190▼
Appropriation of the result
Profit (loss) to be appropriated9906-€444,326-€588,517▼
Profit (loss) brought forward from the previous period14P-€406,150-€444,326▼

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2018201920202021202220232024Change
Non-recurring operating income76A------€461-
Remuneration, social security and pensions62---€67,505€86,171€79,067€60,859▼ 23.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,484€36,622€38,292€44,446€44,685€50,505€50,636▲ 0.3%
Other operating charges640/8---€1,375€79-€1,248-
Non-recurring operating charges66A-----€7,002€5,558▼ 20.6%
Gross operating margin9900-€27,653€47,126€37,660€104,336€126,529€113,346-€5,116-
Operating profit (loss)9901-€110,989-€46,893-€61,951-€8,989-€4,406-€23,227-€123,418▼ 431%
Recurring financial income75€1€49€48-----
Financial charges65/66B---€6,733€6,570€15,701€20,773▲ 32.3%
Recurring financial charges65€2,620€8,031€9,802€6,733€6,570€15,701€20,773▲ 32.3%
Profit (loss) for the period before taxes9903-€113,608-€54,876-€71,704-€15,722-€10,976-€38,928-€144,190▼ 270%
Income taxes67/77€200€126€37---€751--
Profit (loss) for the period9904-€113,808-€55,002-€71,741-€15,722-€10,976-€38,177-€144,190▼ 278%
Profit (loss) for the period to be appropriated9905-€113,808-€55,002-€71,741-€15,722-€10,976-€38,177-€144,190▼ 278%
Line2018201920202021202220232024Change
Assets
Total assets20/58€358,477€359,889€356,905€371,156€392,197€430,128€330,409▼ 23.2%
Formation expenses20€0-€0-----
Fixed assets21/28€186,374€234,168€246,501€267,597€274,996€230,116€183,151▼ 20.4%
Intangible fixed assets21€167,226€219,160€237,613€261,512€251,326€212,195€170,747▼ 19.5%
Tangible fixed assets22/27€18,888€12,397€6,277€3,474€21,059€15,310€9,793▼ 36.0%
Plant, machinery and equipment23---€873€505€137--
Furniture and vehicles24---€2,601€20,554€15,173€9,793▼ 35.5%
Financial fixed assets28€260€2,611€2,611€2,611€2,611€2,611€2,611=
Current assets29/58€172,103€125,720€110,404€103,559€117,201€200,011€147,258▼ 26.4%
Stocks and contracts in progress3€36,804€78,226€52,356€49,015€61,759€118,791€105,675▼ 11.0%
Stocks30/36---€49,015€61,759€118,791€105,675▼ 11.0%
Amounts receivable within one year40/41€111,709€29,918€33,432€28,332€32,176€51,611€14,995▼ 70.9%
Trade receivables40---€24,816€25,951€45,360€14,995▼ 66.9%
Other amounts receivable41---€3,517€6,225€6,252--
Cash at bank and in hand54/58€15,556-€1€12,933€9,988€16,330€13,309▼ 18.5%
Deferred charges and accrued income490/1---€13,279€13,279€13,279€13,279=
Equity and liabilities
Total equity and liabilities10/49€358,477€359,889€356,905€371,156€392,197€430,128€330,409▼ 23.2%
Equity10/15-€103,751-€158,753-€180,094-€195,816-€206,792-€243,926-€388,117▼ 59.1%
Contributions10/11€150,000€150,000-€200,400€200,400€200,400€200,400=
Profit (loss) carried forward14-€253,751-€308,753-€380,494-€396,216-€407,192-€444,326-€588,517▼ 32.5%
Amounts payable17/49€462,228€518,642€536,998€566,972€598,989€674,054€718,526▲ 6.6%
Amounts payable after more than one year17€343,000€428,000€475,000€475,000€475,000€575,000€545,815▼ 5.1%
Financial debts170/4---€475,000€475,000€575,000€545,815▼ 5.1%
Amounts payable within one year42/48€119,228€89,820€61,265€91,972€123,989€99,054€172,710▲ 74.4%
Financial debts43---€0€5,043€2,339€9,304▲ 298%
Credit institutions430/8----€5,043€2,339€9,304▲ 298%
Trade debts44€112,475€47,809€42,664€29,016€10,882€4,927€3,667▼ 25.6%
Suppliers440/4---€29,016€10,882€4,927€3,667▼ 25.6%
Taxes, remuneration and social security45---€14,566€13,025€10,734€8,067▼ 24.8%
Taxes450/3---€3,245€3,122€4,578€1,718▼ 62.5%
Remuneration and social security454/9---€11,321€9,903€6,156€6,349▲ 3.1%
Other amounts payable47/48---€48,390€95,039€81,054€151,672▲ 87.1%
Line2018201920202021202220232024Change
Profit (loss) for the period9904-€113,808-€55,002-€71,741-€15,722-€10,976-€38,177-€144,190▼ 278%
+ Depreciation and write-downs630€29,484€36,622€38,292€44,446€44,685€50,505€50,636▲ 0.3%
Operating cash flow (approximation)-€84,324-€18,380-€33,449€28,724€33,709€12,328-€93,554-
Investment in fixed assets (approximation)--€84,417-€50,624-€65,542-€52,084-€5,625-€3,671▲ 34.7%
Change in cash---€12,933-€2,946€6,342-€3,021-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 12 filings with the National Bank
Financial year Type Filed Reference
31-12-2024 micro format 30-09-2025 2025-00534424
31-12-2023 micro format 20-11-2024 2024-00602019
31-12-2022 micro format 11-08-2023 2023-00324283
31-12-2021 micro format 30-09-2022 2022-20442891
31-12-2020 full format 31-08-2021 2021-66400243
31-12-2019 full format 25-08-2020 2020-44700069
31-12-2018 full format 16-09-2019 2019-64500275
31-12-2017 full format 22-08-2018 2018-51800490
31-12-2016 full format 04-10-2017 2017-66000564
31-12-2015 full format 04-11-2016 2016-67400192

Show all 12 filings

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 97 active companies whose main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209), figures are known for 74. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.